Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Oct 28, 2021 Bullish $44.46 X 0
Rybkarybka Rybkarybka Merchant
Oct 28, 2021 $47.70 +7.29% $44.46 X 92.71% 0
Rybkarybka Rybkarybka Merchant
Oct 15, 2021 $54.80 +10.28% $49.69 X 89.72% 0
JS JS Pro
Oct 12, 2021 $51.26 -1.20% $51.88 X 98.80% 2
Rybkarybka Rybkarybka Merchant
Oct 12, 2021 $48.60 -6.32% $51.88 X 93.68% 0
Rybkarybka Rybkarybka Merchant
Oct 11, 2021 $51.90 +1.61% $51.08 X 98.39% 0
JS JS Pro
Oct 8, 2021 $55.49 +7.77% $51.49 X 92.23% 0
AlexVel AlexVel Pro
Oct 8, 2021 $53.75 +4.39% $51.49 X 95.61% 0
Rybkarybka Rybkarybka Merchant
Oct 8, 2021 $54.10 +5.07% $51.49 X 94.93% 0
JS JS Pro
Oct 7, 2021 $50.24 -6.30% $53.62 X 93.70% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE